Nurse Practitioner · Las Vegas, NV
NPI
1548837610
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3150 N Tenaya Way Ste 525
Las Vegas, NV, 89128
Phone (725) 204-6520
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,817 services
Medicare patients, 2024
152
Average age 61
Drug cost, 2024
$2.1M
3,870 prescriptions
Company payments, 2025
$1,180
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John T Blakemore was code 99213 (office e&m - established), 170 times for 132 patients. In total John T Blakemore billed 1,817 services in 10 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 170 | 132 | $45.12 | $7,671 |
By year: 2022 $13K for 347 services; 2023 $26K for 2,667 services; 2024 $19K for 1,817 services.
Medicare prescription drug claims, 2024
In 2024, the drug John T Blakemore prescribed most often to Medicare patients was Lacosamide, with 247 prescriptions and refills. In total John T Blakemore wrote 3,870 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 247 | 306 | 47 | $26K |
| Levetiracetam Generic | 243 | 401 | 56 | $11K |
| Lamotrigine Generic | 223 | 350 | 47 | $3,934 |
| Briviact Brivaracetam | 192 | 192 | 30 | $300K |
| Clonazepam Generic | 188 | 189 | 32 | $2,232 |
| Gabapentin Generic | 160 | 223 | 33 | $2,754 |
| Clobazam Generic | 131 | 139 | 16 | $25K |
| Topiramate Generic | 125 | 184 | 29 | $1,517 |
| Xcopri Cenobamate | 88 | 90 | 15 | $142K |
| Zonisamide Generic | 85 | 130 | 16 | $3,072 |
| Donepezil Hcl Generic | 84 | 148 | 24 | $746 |
| Nurtec Odt Rimegepant Sulfate | 76 | 76 | 17 | $97K |
| Lamotrigine Er Lamotrigine | 74 | 132 | 19 | $19K |
| Memantine Hcl Generic | 67 | 110 | 21 | $1,254 |
| Epidiolex Cannabidiol (Cbd) | 66 | 66 | Under 11 | $239K |
Brand drugs: 855 claims; generic drugs: 2,979 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John T Blakemore $1,180 ($1,180 in general payments such as food, travel and fees) from 12 companies. The largest payer was SK Life Science, Inc. with $331.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 8 | $331 |
| Biogen, Inc. BIIB | 7 | $167 |
| Grifols USA, LLC | 1 | $150 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $89.31 |
| Abbvie Inc. ABBV | 4 | $69.74 |
| UCB, Inc. UCB.BR | 3 | $61.23 |
| Ceribell, Inc. CBLL | 1 | $59.84 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $59.19 |
| Genzyme Corporation SNY | 2 | $55.91 |
| Janssen Biotech, Inc. JNJ | 2 | $52.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.